Bumper Offer - Urjas oil Just @ Rs. 1
Vomikind Injection 2ml, a prescription drug, is manufactured in various forms such as Injection. Nausea and Vomiting are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Vomikind Injection 2ml. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
While these are the most often observed Vomikind Injection 2ml side effects, there are can be others also. These have been listed below. These side effects of Vomikind Injection 2ml are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Vomikind Injection 2ml's effect is Safe during pregnancy and Mild for lactating mothers. Further, the section on Vomikind Injection 2ml related warnings talks about Vomikind Injection 2ml's effects on the liver, heart and kidney.
Vomikind Injection 2ml is contraindicated in people with pre-existing medical conditions like Heart Disease, Calcium Deficiency, Potassium Deficiency as it can result in adverse effects. The section on Vomikind Injection 2ml contraindications lists all such conditions.
Drug interactions for Vomikind Injection 2ml have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Vomikind Injection 2ml is not safe while driving, and is is not addictive in nature.
Vomikind Injection 2ml is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Is the use of Vomikind Injection 2ml safe for pregnant women?
Vomikind is safe for pregnant women.
Is the use of Vomikind Injection 2ml safe during breastfeeding?
Vomikind has been seen to have minimal side effects on breastfeeding women.
What is the effect of Vomikind Injection 2ml on the Kidneys?
There are no side effects of Vomikind on the kidneys.
What is the effect of Vomikind Injection 2ml on the Liver?
Vomikind may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Vomikind Injection 2ml on the Heart?
The heart can be affected by Vomikind. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Vomikind Injection 2ml should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Vomikind Injection 2ml unless your doctor advises you to do so -
Is this Vomikind Injection 2ml habit forming or addictive?
No, there is no any evidence that Vomikind Injection 2ml is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Vomikind Injection 2ml you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Vomikind Injection 2ml only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Vomikind Injection 2ml in mental disorders is not effective.
Interaction between Food and Vomikind Injection 2ml
Taking Vomikind Injection 2ml with food does not harm your health.
Interaction between Alcohol and Vomikind Injection 2ml
Consumption of alcohol and Vomikind Injection 2ml together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)